## Gene Summary
SSTR5, or somatostatin receptor type 5, is one of the five somatostatin receptors in humans. This receptor is a G protein-coupled receptor that mediates the antiproliferative action of somatostatin, a peptide hormone that influences neurotransmission and cell proliferation through interaction with G proteins that activate a tyrosine phosphatase. SSTR5 is widely expressed in various tissues, including the pituitary gland, pancreas, and the intestines. It binds somatostatin-14 and somatostatin-28, which are ubiquitous inhibitors of endocrine, neuroendocrine, and exocrine secretions.

## Gene Drugs, Diseases, Phenotypes, and Pathways
SSTR5 is implicated in various physiological processes through its regulation of somatostatin in the body. It has a crucial role in signaling pathways related to anti-proliferation, hormone secretion, and cell growth inhibition. Abnormalities or variations in SSTR5 expression or function have been associated with several diseases such as acromegaly, diabetes, and some gastrointestinal diseases, due to its wide-ranging effects on hormone secretion. SSTR5 modulates numerous somatostatin-related effects crucial for endocrine and exocrine functions and is particularly important for its regulatory roles in the pituitary axis.

## Pharmacogenetics
The pharmacogenetics of SSTR5 includes its responsiveness to therapeutic agents like pasireotide, a somatostatin analog that targets multiple somatostatin receptors including SSTR5 and is utilized primarily in the treatment of Cushing's disease and acromegaly. Genetic variations in SSTR5 can influence the efficacy and tolerability of such treatments. Understanding individual differences in SSTR5 genetics can be critical in optimizing therapeutic strategies that target this receptor, particularly in diseases associated with hormone excess. Moreover, research into SSTR5 pharmacogenetics offers potential for personalized medicine approaches in managing conditions associated with this receptor, leveraging the modulation of its pathways for more effective and targeted therapies.